Why Is ProAir So Hard to Find? [Explained for 2026]

If you've stood at a pharmacy counter only to be told your albuterol inhaler is out of stock, you're not imagining things. ProAir — one of the most prescribed rescue inhalers in the country — has been genuinely difficult to find at times over the past few years. The reasons are layered, but understanding them can help you plan ahead and avoid gaps in your medication supply.

What Is ProAir and Why Do So Many People Need It?

ProAir is a brand name for albuterol sulfate, a short-acting beta agonist (SABA) used to quickly open narrowed airways during an asthma attack or COPD flare. It works within 5 minutes and provides relief for 4 to 6 hours. Tens of millions of Americans use albuterol as their go-to rescue inhaler — it's one of the most commonly dispensed prescription medications in the United States.

ProAir has come in several forms: the ProAir HFA (a pressurized metered-dose inhaler), the ProAir RespiClick (a dry powder inhaler), and the ProAir Digihaler (a smart inhaler connected to an app). Because so many people depend on albuterol daily, even small disruptions in the supply chain ripple out quickly.

The Short History: What Caused the ProAir Shortage?

Several events converged to create the albuterol availability crisis that began in 2022 and continues to affect certain formulations today.

October 2022: The FDA added albuterol sulfate inhalation solution (the liquid form used in nebulizers) to its official drug shortage list. At the same time, Teva Pharmaceuticals discontinued the brand-name ProAir HFA inhaler, though an authorized generic continued to be produced. For most patients using HFA inhalers, this wasn't an immediate problem — but it was a sign of fragility in the supply chain. See our full ProAir shortage update for the latest status.

February 2023: Akorn Pharmaceuticals, one of the primary U.S. manufacturers of liquid albuterol (nebulizer solution), filed for Chapter 7 bankruptcy and closed three manufacturing plants in New Jersey, New York, and Illinois. This left Nephron Pharmaceuticals as essentially the sole domestic producer of liquid albuterol. When demand outpaced Nephron's capacity — especially during a simultaneous flu, RSV, and COVID surge — hospitals and home patients found themselves unable to get the nebulizer solution they depended on.

2023–2025: The nebulizer solution shortage persisted through repeated respiratory virus seasons. Pediatric hospitals across the country reported difficulty maintaining adequate stock. Meanwhile, albuterol HFA inhalers for individual use remained relatively available at most pharmacies — though local stock-outs during peak respiratory months became increasingly common.

Late 2025 – Early 2026: The FDA approved two new generic albuterol manufacturers — Ritedose Pharmaceuticals in November 2025 and Amneal Pharmaceuticals in March 2026. These additions to the supply chain are expected to gradually ease both nebulizer solution and inhaler availability, though it may take several months before the full impact is felt at the pharmacy level.

Which Forms of Albuterol Are Most Affected?

Not all albuterol products have been equally affected. Understanding the difference can help you figure out which option is most available to you:

Albuterol HFA inhalers (ProAir HFA generic, Ventolin HFA, Proventil HFA): Generally available at most pharmacies, but local stock-outs occur — especially during fall and winter respiratory virus peaks.

Albuterol nebulizer solution: Most severely affected. On the FDA shortage list since October 2022. Improving in 2026 but still subject to local shortages.

ProAir RespiClick (dry powder inhaler): Has not been significantly affected by the shortage and may be an easier-to-find option for eligible patients.

Why Doesn't the Market Just Make More?

This is the question patients and policymakers alike have been asking. The answer comes down to economics. Albuterol is a decades-old generic drug. Its profit margins are thin, which means fewer manufacturers are willing to invest in producing it at scale. When one manufacturer exits the market — as Akorn did in 2023 — the remaining suppliers can't instantly ramp up to fill the gap. Building new drug manufacturing capacity takes time, regulatory approval, and significant capital investment.

The FDA has identified "lack of incentives to produce less profitable drugs" as a root cause of drug shortages in its published reports. Albuterol is a prime example — essential to millions of patients, yet economically unattractive to produce because competition has driven prices so low.

Why Do Stock-Outs Spike in Fall and Winter?

Even when supply is nominally adequate, demand spikes during respiratory virus season — typically October through March. Flu, RSV, and COVID all trigger respiratory flares that increase albuterol use. Additionally, winter allergens and cold air are common asthma triggers. This seasonal demand surge can overwhelm pharmacy stock levels in a matter of days, leading to widespread local shortages even when there's no national supply crisis.

What Should You Do If You Can't Find ProAir?

If your pharmacy is out of stock, here are immediate steps to take:

Use medfinder. medfinder calls pharmacies near you to find which ones have ProAir or generic albuterol in stock. This saves you hours of calling around yourself.

Ask about therapeutic alternatives. Ventolin HFA and Proventil HFA contain the same active ingredient (albuterol sulfate) and are often interchangeable with a new prescription. ProAir RespiClick may also be available.

Talk to your doctor about levalbuterol. Levalbuterol (Xopenex HFA) is a chemically related rescue inhaler that some patients may tolerate even better than albuterol, though it's typically more expensive.

Refill early — don't wait until you're out. Most insurance plans allow you to refill an inhaler when you have less than a week's supply left. Don't wait until your inhaler runs out — especially heading into respiratory season.

Try independent pharmacies. When chain pharmacies are out, independent pharmacies sometimes have better or different stock. They may also have more flexibility with sourcing.

Is the ProAir Shortage Getting Better in 2026?

Yes, there are real signs of improvement. With two new FDA-approved generic manufacturers entering the market in late 2025 and early 2026, supply is expected to grow steadily throughout the year. However, local stock-outs will likely still occur during peak respiratory season. The best strategy is to plan ahead, refill early, and know your options before you need them. Read our guide on how to find ProAir in stock near you for specific tools and strategies.

If you're struggling to locate ProAir or generic albuterol right now, medfinder can help. You provide your medication, dose, and zip code — and medfinder calls nearby pharmacies to find which ones can fill it. Results are texted to you. No more calling around yourself.